Article
Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
European review for medical and pharmacological sciences - 1 Oct 2017
Feng Y, Zhang Q, Wang J, Liu P
Abstract excerpt
OBJECTIVE: The clinical significance and biological functions of long non-coding RNA AFAP1-AS1 in gastric cancer (GC) remain larger elucidated. The aim of the study is to investigate the role of lncRNA AFAP1-AS1 involved in GC progression. PATIENTS AND METHODS: Quantitative reverse transcription-polymerase chain reaction (QRT-PCR) assay was used to evaluate the expression of lncRNA AFAP1-AS1 in GC tissues, when...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
